[1]黄　笑,杨　倩,吕冬晨,等.阻塞性睡眠呼吸暂停低通气综合征与射血分数保留型心力衰竭的关系研究进展[J].新乡医学院学报,2022,39(7):683-687.[doi:10.7683/xxyxyxb.2022.07.017]
　HUANG Xiao,YANG Qian,LYU Dongchen,et al.Research progress on the relationship between obstructive sleep apnea hypopnea syndrome and heart failure with preserved ejection fraction[J].Journal of Xinxiang Medical University,2022,39(7):683-687.[doi:10.7683/xxyxyxb.2022.07.017]
点击复制

阻塞性睡眠呼吸暂停低通气综合征与射血分数保留型心力衰竭的关系研究进展
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年7
页码:
683-687
栏目:
综述
出版日期:
2022-07-05

文章信息/Info

Title:
Research progress on the relationship between obstructive sleep apnea hypopnea syndrome and heart failure with preserved ejection fraction
作者:
黄　笑; 杨　倩; 吕冬晨; 袁　宇
（新乡医学院第一附属医院心血管内科，河南　卫辉　453100）
Author(s):
HUANG Xiao; YANG Qian; LYU Dongchen; YUAN Yu
(Department of Cardiology，the First Affiliated Hospital of Xinxiang Medical University，Weihui 453100，Henan Province，China)
关键词:
阻塞性睡眠呼吸暂停低通气综合征; 射血分数保留型心力衰竭; 持续气道正压通气
Keywords:
obstructive sleep apnea hypopnea syndrome; heart failure with preserved ejection fraction; continuous positive airway pressure
分类号:
R543
DOI:
10.7683/xxyxyxb.2022.07.017
文献标志码:
A
摘要:
阻塞性睡眠呼吸暂停低通气综合征（OSAHS）是一种常见且尚未得到重视的慢性呼吸系统疾病，被认为是心力衰竭等多种心血管疾病的独立危险因素。研究表明，OSAHS与射血分数保留型心力衰竭(HFpEF)的发生、发展密切相关；但关于OSAHS与HFpEF之间相关的病理生理学机制尚不明确，OSAHS如何参与HFpEF的发生和发展成为目前研究的热点。基于此，本文就OSAHS的病理生理学机制、OSAHS参与HFpEF发生和发展的机制以及持续气道正压通气治疗对HFpEF的影响加以综述，旨在为早期诊断和治疗OSAHS、降低HFpEF的发病率和病死率提供参考。
Abstract:
Obstructive sleep apnea hypopnea syndrome (OSAHS) is a common and neglected chronic respiratory disease.It is considered as an independent risk factor for many cardiovascular diseases such as heart failure.Relevant studies have shown that OSAHS is closely related to the occurrence and development of heart failure with preserved ejection fraction (HFpEF).However,at present,the pathophysiological mechanism between OSAHS and HFpEF is not clear.Based on this,this paper reviews the pathophysiology mechanism of OSAHS,the mechanism of OSAHS involving in the occurrence and development of HFpEF,and the effects of continuous positive airway pressure treatment on HFpEF,in order to provide clinical reference for early diagnosis and treatment of OSAHS to reduce the incidence and mortality of HFpEF.

参考文献/References:

［1］　SORIMACHI H,OMOTE K,BORLAUG B A.Clinical phenogroups in heart failure with preserved ejection fraction［J］.Heart Fail Clin,2021,17(3):483-498.
［2］　XU C,YU F,MAO S,et al.Lipoprotein-associated phospholipase A2 predicted cardiovascular disease in obstructive sleep apnea syndrome［J］.Respir Med,2020,163:105881.
［3］　MART-ALMOR J,JIMNEZ-LPEZ J,CASTEIGT B,et al.Obstructive sleep apnea syndrome as a trigger of cardiac arrhythmias［J］.Curr Cardiol Rep,2021,23(3):20.
［4］　YEGHIAZARIANS Y,JNEID H,TIETJENS J R,et al.Obstructive sleep apnea and cardiovascular disease:a scientific statement from the american heart association［J］.Circulation,2021,14(3):e56-e67.
［5］　COWIE M R,LINZ D,REDLINE S,et al.Sleep disordered breathing and cardiovascular disease:JACC state-of-the-art review［J］.J Am Coll Cardiol,2021,78(6):608-624.
［6］　AZARBARZIN A,SANDS S A,TARANTO M L,et al.The sleep apnea-specific hypoxic burden predicts incident heart failure［J］.Chest,2020,158(2):739-750.
［7］　SANDERSON J E,FANG F,LU M,et al.Obstructive sleep apnoea,intermittent hypoxia and heart failure with a preserved ejection fraction［J］.Heart,2021,107(3):190-194.
［8］　FLORAS J S.Sleep apnea and cardiovascular disease:an enigmatic risk factor［J］.Circ Res,2018,122(12):1741-1764.
［9］　YAN Y R,ZHANG L,LIN Y N,et al.Chronic intermittent hypoxia-induced mitochondrial dysfunction mediates endothelial injury via the TXNIP/NLRP3/IL-1β signaling pathway［J］.Free Radic Biol Med,2021,165:401-410.
［10］　VISNIAUSKAS B,PERRY J C,GOMES G N,et al.Intermittent hypoxia changes the interaction of the kinin-VEGF system and impairs myocardial angiogenesis in the hypertrophic heart［J］.Physiol Rep,2021,9(9):e14863.
［11］　STANEK A,BRO Z YNA-TKACZYK K,MYSLINSKI W.Oxidative stress markers among obstructive sleep apnea patients［J］.Oxid Med Cell Longev,2021,2021:9681595.
［12］　MANIACI A,IANNELLA G,COCUZZA S,et al.Oxidative stress and inflammation biomarker expression in obstructive sleep apnea patients［J］.J Clin Med,2021,10(2):277.
［13］　SPIESSHOEFER J,LINZ D,SKOBEL E,et al.Sleep-the yet underappreciated player in cardiovascular diseases:a clinical review from the german cardiac society working group on sleep disordered breathing［J］.Eur J Prev Cardiol,2019,28(2):189-200.
［14］　LI Y,WANG Y.Obstructive sleep apnea-hypopnea syndrome as a novel potential risk for aging［J］.Aging Dis,2021,12(2):586-596.
［15］　SHAH S J,BORLAUG B A,KITZMAN D W,et al.Research prio-rities for heart failure with preserved ejection fraction:national heart,lung,and blood institute working group summary［J］.Circulation,2020,141(12):1001-1026.
［16］　WANG J,COVASSIN N,DAI T,et al.Therapeutic value of treating central sleep apnea by adaptive servo-ventilation in patients with heart failure:a systematic review and meta-analysis［J］.Heart Lung,2021,50(2):344-351.
［17］　HAN Y C,SHEN Z J,ZHANG S Y,et al.Efficacy of adaptive servo-ventilation and continuous positive airway pressure treatment in chronic heart failure with sleep-disordered breathing:a systematic review and meta-analysis［J］.Heart Fail Rev,2021,26(3):521-529.
［18］　HERNANDEZ A V,JEON A,DENEGRI-GALVAN J,et al.Use of adaptive servo ventilation therapy as treatment of sleep-disordered breathing and heart failure:a systematic review and meta-analysis［J］.Sleep Breath,2020,24(1):49-63.
［19］　DHARUMAN S,AJITH KUMAR S, KANAKASABAPATHY BALAJI S,et al.Evaluation of levels of advanced oxidative protein products in patients with polycystic ovary syndrome with and without chronic periodontitis:a cross-sectional study［J］.Int J Fertil Steril,2022,16(1):55-59.
［20］　XUE Y,ZHANG M,LIU M,et al.8-Gingerol ameliorates myocardial fibrosis by attenuating reactive oxygen species,apoptosis,and autophagy via the PI3K/Akt/mTOR Signaling pathway［J］.Front Pharmacol,2021,12:711701.
［21］　MARTINS S G,ZILHAO R,THORSTEINSDOTTIR S,et al.Linking oxidative stress and DNA damage to changes in the expression of extracellular matrix components［J］.Front Genet,2021,12:673002.
［22］　FRANCZAK A,SKOMRO R,SAWICKA J,et al.Serum matrix metalloproteinase-2 as a predictor of level of hypoxemia and severity of obstructive sleep apnea［J］.Sleep Breath,2021,25(2):877-886.
［23］　GRAKOVA E V,YAKOVLEV A V,SHILOV S N,et al.Heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome:prognostic value of biomarkers［J］.Kardiologiia,2021,61(11):77-88.
［24］　XIE J Y,LIU W X,JI L,et al.Relationship between inflammatory factors and arrhythmia and heart rate variability in OSAS patients［J］.Eur Rev Med Pharmacol Sci,2020,24(4):2037-2053.
［25］　WANG Z H,ZHU D,XIE S,et al.Inhibition of rho-kinase attenuates left ventricular remodeling caused by chronic intermittent hypoxia in rats via suppressing myocardial inflammation and apoptosis［J］.J Cardiovasc Pharmacol,2017,70(2):102-109.
［26］　PENG L,LI Y,LI X,et al.Extracellular vesicles derived from intermittent hypoxia-treated red blood cells impair endothelial function through regulating eNOS phosphorylation and ET-1 expression［J］.Cardiovasc Drugs Ther,2021,35(5):901-913.
［27］　HARANCZYK M,KONIECZYNSKA M,PLAZAK W.Endothelial dysfunction in obstructive sleep apnea patients［J］.Sleep Breath,2022,26(1):231-242.
［28］　SICA E,DE BERNARDI F,NOSETTI L,et al.Catecholamines and children obstructive sleep apnea:a systematic review［J］.Sleep Med,2021,87:227-232.
［29］　CETIN-ATALAY R,MELITON A Y,WU D,et al.Intermittent hypoxia-induced activation of endothelial cells is mediated via sympathetic activation-dependent catecholamine release［J］.Front Physiol,2021,12:701995.
［30］　GREENLUND I M,CARTER J R.Sympathetic neural responses to sleep disorders and insufficiencies［J］.Am J Physiol Heart Circ Physiol,2022,322(3):H337-H349.
［31］　NICHOLL D,HANLY P J,ZALUCKY A A,et al.Nocturnal hypoxemia severity influences the effect of CPAP therapy on renal renin-angiotensin-aldosterone system activity in humans with obstructive sleep apnea［J］.Sleep,2021,44(5):zsaa228.
［32］　CLARK D R,AHMED M I,CALHOUN D A.Resistant hypertension and aldosterone:an update［J］.Can J Cardiol,2012,28(3):318-325.
［33］　DEEP SINGH T.Abnormal sleep-related breathing related to heart failure［J］.Sleep Med Clin,2022,17(1):87-98.
［34］　JUNG J H,PARK J W,KIM D H,et al.The effects of obstructive sleep apnea on risk factors for cardiovascular diseases［J］.Ear Nose Throat J,2021,100(5_suppl):S477-S482.
［35］　BRUNETTI V,DELLA MARCA G,SERVIDEI S,et al.Sleep disorders in mitochondrial diseases［J］.Curr Neurol Neurosci Rep,2021,21(7):30.
［36］　VAKULIN A,GREEN M A,D′ROZARIO A L,et al.Brain mitochondrial dysfunction and driving simulator performance in untreated obstructive sleep apnea［J］.J Sleep Res,2022,31(2):e13482.
［37］　LIN C C,CHEN W J,SUN Y K,et al.Continuous positive airway pressure affects mitochondrial function and exhaled PGC1-α levels in obstructive sleep apnea［J］.Exp Lung Res,2021,47(10):476-486.
［38］　TEMPAKU P F,D′ALMEIDA V,DA SILVA S M A,et al.Klotho genetic variants mediate the association between obstructive sleep apnea and short telomere length［J］.Sleep Med,2021,83:210-213.
［39］　TURKIEWICZ S,DITMER M,SOCHAL M,et al.Obstructive sleep apnea as an acceleration trigger of cellular senescence processes through telomere shortening［J］.Int J Mol Sci,2021,22(22):12536.
［40］　LIN C C,CHEN W J,SUN Y K,et al.Effects of continuous positive airway pressure on resolvin and matrix metalloproteinase-9 in patients with obstructive sleep apnea［J］.Respir Physiol Neurobiol,2021,285:103603.
［41］　WANG X,YUE Z,LIU Z,et al.Continuous positive airway pressure effectively ameliorates arrhythmias in patients with obstructive sleep apnea-hypopnea via counteracting the inflammation［J］.Am J Otolaryngol,2020,41(6):102655.
［42］　YOSHIHISA A,SUZUKI S,YAMAKI T,et al.Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing［J］.Eur J Heart Fail,2013,15(5):543-550.
［43］　D′ELIA E,FERRERO P,VITTORIV C,et al.Beneficial effects of adaptive servo-ventilation on natriuretic peptides and diastolic function in acute heart failure patients with preserved ejection fraction and sleep-disordered breathing［J］.Sleep Breath,2019,23(1):287-291.
［44］　CARRATU P,DRAGONIERID S,PORTINCASA P.Right ventricular diastolic dysfunction might correlate with body mass index as well as with AHI in patients with obstructive sleep apnea syndrome［J］.Echocardiography,2020,37(10):1701.

相似文献/References:

[1]董彦玲,来俊英.阻塞性睡眠呼吸暂停低通气综合征的围手术期护理[J].新乡医学院学报,2008,25(02):208.
[2]殷波.低温等离子射频消融术治疗阻塞性睡眠呼吸暂停低通气综合征[J].新乡医学院学报,2011,28(01):084.
[3]刘丹,吴润华,陈乃洁,等.阻塞性睡眠呼吸暂停低通气综合征患者胰岛素抵抗发生机制及治疗研究进展[J].新乡医学院学报,2023,40(10):986.[doi:10.7683/xxyxyxb.2023.10.015]
　LIU Dan,WU Runhua,CHEN Naijie,et al.Research progress of the pathogenesis and treatment of insulin resistance in patients with obstructive sleep apnea hypopnea syndrome[J].Journal of Xinxiang Medical University,2023,40(7):986.[doi:10.7683/xxyxyxb.2023.10.015]

更新日期/Last Update: 2022-07-05